Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca May Not Be Immune To Patent Cliff But Dividend Is Solid
AstraZeneca May Not Be Immune To Patent Cliff But Dividend Is Solid
AstraZeneca May Not Be Immune To Patent Cliff But Dividend Is Solid
Submitted by
admin
on October 29, 2012 - 10:35am
Source:
Seeking Alpha
News Tags:
patent cliff
AstraZeneca
dividends
Headline:
AstraZeneca May Not Be Immune To Patent Cliff But Dividend Is Solid
Do Not Allow Advertisers to Use My Personal information
